Area of research
Nephrology · Hematology
Research interest
Research interests include Dialysis and Renal Disease Management, Erythropoietin and Anemia Treatment, Asthma and respiratory diseases, and Allergic Rhinitis and Sensitization.
Adherence to Treatment in Allergic Rhinitis During the Pollen Season in Europe: A MASK‐air Study
Allergic Rhinitis and Its Impact on Asthma ( <scp>ARIA</scp> )‐ <scp>EAACI</scp> Guidelines—2024–2025 Revision: Part I—Guidelines on Intranasal Treatments
Methodology for the Development of the Allergic Rhinitis and Its Impact on Asthma ( <scp>ARIA</scp> )‐EAACI 2024–2025 Guidelines: From Evidence‐to‐Decision Frameworks to Digitalised Shared Decision‐Making Algorithms
Poor Rhinitis and Asthma Control Is Associated With Decreased Health-Related Quality of Life and Utilities: A MASK-air Study
Relevance of individual bronchial symptoms for asthma diagnosis and control in patients with rhinitis: A MASK‐air study
Rhinitis associated with asthma is distinct from rhinitis alone: The <scp>ARIA‐MeDALL</scp> hypothesis
Digitally‐enabled, patient‐centred care in rhinitis and asthma multimorbidity: The ARIA‐MASK‐air<sup>®</sup>approach
Patient‐centered digital biomarkers for allergic respiratory diseases and asthma: The <scp>ARIA‐EAACI</scp> approach – ARIA‐EAACI Task Force Report
Adherence to inhaled corticosteroids and long-acting β2-agonists in asthma: A MASK-air study
Behavioural patterns in allergic rhinitis medication in Europe: A study using MASK‐air<sup>®</sup> real‐world data
The Allergic Rhinitis and Its Impact on Asthma (ARIA) Approach of Value-Added Medicines: As-Needed Treatment in Allergic Rhinitis
Real‐world data using mHealth apps in rhinitis, rhinosinusitis and their multimorbidities
Comparison of rhinitis treatments using <scp>MASK</scp>‐air® data and considering the minimal important difference
Consistent trajectories of rhinitis control and treatment in 16,177 weeks: The <scp>MASK</scp>‐air® longitudinal study
Cutoff Values of MASK-air Patient-Reported Outcome Measures
Allergen immunotherapy in MASK‐air users in real‐life: Results of a Bayesian mixed‐effects model
Management of allergic rhinitis symptoms in the pharmacy Pocket guide 2022
Development and validation of combined symptom‐medication scores for allergic rhinitis*
Assessment of the Control of Allergic Rhinitis and Asthma Test (CARAT) using MASK-air
Heterogeneity of the pharmacologic treatment of allergic rhinitis in Europe based on MIDAS and OTCims platforms
Digital Health Europe (DHE) Twinning on severe asthma—kick-off meeting report
ARIA digital anamorphosis: Digital transformation of health and care in airway diseases from research to practice
Treatment of allergic rhinitis during and outside the pollen season using mobile technology. A MASK study
Managing Allergic Rhinitis in the Pharmacy: An ARIA Guide for Implementation in Practice
ARIA 2019: Um Percurso Assistencial Integrado para a Rinite Alérgica em Portugal
Next-generation Allergic Rhinitis and Its Impact on Asthma (ARIA) guidelines for allergic rhinitis based on Grading of Recommendations Assessment, Development and Evaluation (GRADE) and real-world evidence
2019 ARIA Care pathways for allergen immunotherapy
Mobile technology offers novel insights into the control and treatment of allergic rhinitis: The MASK study
Guidance to 2018 good practice: ARIA digitally-enabled, integrated, person-centred care for rhinitis and asthma
Next-generation ARIA care pathways for rhinitis and asthma: a model for multimorbid chronic diseases